Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)

China flag China · Delayed Price · Currency is CNY
14.36
-0.12 (-0.83%)
Apr 28, 2026, 3:00 PM CST
-26.32%
Market Cap 28.40B
Revenue (ttm) 6.17B
Net Income (ttm) 1.09B
Shares Out 1.98B
EPS (ttm) 0.55
PE Ratio 26.11
Forward PE 22.81
Dividend 0.20 (1.38%)
Ex-Dividend Date Sep 25, 2025
Volume 7,576,824
Average Volume 9,470,291
Open 14.46
Previous Close 14.48
Day's Range 14.32 - 14.57
52-Week Range 14.32 - 22.08
Beta 0.28
RSI 32.94
Earnings Date Apr 30, 2026

About SHA:600161

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally. Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin; human coagulation factors VIII; human fibrinogen;... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1966
Employees 5,205
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600161
Full Company Profile

Financial Performance

In 2025, SHA:600161's revenue was 6.17 billion, an increase of 2.26% compared to the previous year's 6.03 billion. Earnings were 1.09 billion, a decrease of -29.59%.

Financial Statements

News

There is no news available yet.